Search results for the GEO ID: GSE2880
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM53412
GPL1355
brain, brainstem: PB1_e1_le1 brain, brainstem Phenytoin brainstem 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53413
GPL1355
brain, brainstem: PB2_e1_le1 brain, brainstem Phenytoin brainstem 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53414
GPL1355
brain, brainstem: PB3_e1_le1 brain, brainstem Phenytoin brainstem 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53415
GPL1355
brain, brainstem: PB4_e1_le1 brain, brainstem Phenytoin brainstem 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53416
GPL1355
brain, brainstem: PB5_e1_le1 brain, brainstem Phenytoin brainstem 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53417
GPL1355
brain, brainstem: PB6_e1_le1 brain, brainstem Phenytoin brainstem 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53418
GPL1355
brain, brainstem: PB7_e1_le1 brain, brainstem Phenytoin brainstem 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53419
GPL1355
brain, hippocampus: PH1_e1_le1 brain, hippocampus Phenytoin hippocampus 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53420
GPL1355
brain, hippocampus: PH2_e1_le1 brain, hippocampus Phenytoin hippocampus 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53421
GPL1355
brain, hippocampus: PH3_e1_le1 brain, hippocampus Phenytoin hippocampus 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53422
GPL1355
brain, hippocampus: PH4_e1_le1 brain, hippocampus Phenytoin hippocampus 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53423
GPL1355
brain, hippocampus: PH5_e1_le1 brain, hippocampus Phenytoin hippocampus 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53424
GPL1355
brain, hippocampus: PH6_e1_le1 brain, hippocampus Phenytoin hippocampus 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53425
GPL1355
brain, hippocampus: PH7_e1_le1 brain, hippocampus Phenytoin hippocampus 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53426
GPL1355
brain, brainstem: LB1_e1_le1 brain, brainstem Levitiracetam brainstem 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days. Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53427
GPL1355
brain, brainstem: LB2_e1_le1 brain, brainstem Levitiracetam brainstem 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days. Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53428
GPL1355
brain, brainstem: LB3_e1_le1 brain, brainstem Levitiracetam brainstem 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53429
GPL1355
brain, brainstem: LB4_e1_le1 brain, brainstem Levitiracetam brainstem 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53430
GPL1355
brain, brainstem: LB5_e1_le1 brain, brainstem Levitiracetam brainstem 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53431
GPL1355
brain, brainstem: LB6_e1_le1 brain, brainstem Levitiracetam brainstem 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53432
GPL1355
brain, brainstem: LB7_e1_le1 brain, brainstem Levitiracetam brainstem 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53433
GPL1355
brain, hippocampus: LH1_e1_le1 brain, hippocampus Levitiracetam hippocampus 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53434
GPL1355
brain, hippocampus: LH2_e1_le1 brain, hippocampus Levitiracetam hippocampus 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53435
GPL1355
brain, hippocampus: LH3_e1_le1 brain, hippocampus Levitiracetam hippocampus 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53436
GPL1355
brain, hippocampus: LH4_e1_le1 brain, hippocampus Levitiracetam hippocampus 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53437
GPL1355
brain, hippocampus: LH5_e1_le1 brain, hippocampus Levitiracetam hippocampus 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53438
GPL1355
brain, hippocampus: LH6_e1_le1 brain, hippocampus Levitiracetam hippocampus 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53439
GPL1355
brain, hippocampus: LH7_e1_le1 brain, hippocampus Levitiracetam hippocampus 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53440
GPL1355
brain, brainstem: CB1_e1_le1 brain, brainstem Control brainstem 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53441
GPL1355
brain, brainstem: CB2_e1_le1 brain, brainstem Control brainstem 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53442
GPL1355
brain, brainstem: CB3_e1_le1 brain, brainstem Control brainstem 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53443
GPL1355
brain, brainstem: CB4_e1_le1 brain, brainstem Control brainstem 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53444
GPL1355
brain, brainstem: CB5_e1_le1 brain, brainstem Control brainstem 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53445
GPL1355
brain, brainstem: CB6_e1_le1 brain, brainstem Control brainstem 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53446
GPL1355
brain, brainstem: CB7_e1_le1 brain, brainstem Control brainstem 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53447
GPL1355
brain, hippocampus: CH1_e1_le1 brain, hippocampus Control hippocampus 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53448
GPL1355
brain, hippocampus: CH2_e1_le1 brain, hippocampus Control hippocampus 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53449
GPL1355
brain, hippocampus: CH3_e1_le1 brain, hippocampus Control hippocampus 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53450
GPL1355
brain, hippocampus: CH4_e1_le1 brain, hippocampus Control hippocampus 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53451
GPL1355
brain, hippocampus: CH5_e1_le1 brain, hippocampus Control hippocampus 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53452
GPL1355
brain, hippocampus: CH6_e1_le1 brain, hippocampus Control hippocampus 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53453
GPL1355
brain, hippocampus: CH7_e1_le1 brain, hippocampus Control hippocampus 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53454
GPL1355
brain, frontal cortex: Sample43_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53455
GPL1355
brain, frontal cortex: Sample44_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53456
GPL1355
brain, frontal cortex: Sample45_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53457
GPL1355
brain, frontal cortex: Sample46_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53458
GPL1355
brain, frontal cortex: Sample47_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53459
GPL1355
brain, frontal cortex: Sample48_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53460
GPL1355
brain, frontal cortex: Sample49_e1_le1 brain, frontal cortex Levitiracetam frontal cortex 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive levetiracetam (150 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53461
GPL1355
brain, frontal cortex: Sample50_e1_le1 brain, frontal cortex Phenytoin frontal cortex 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53462
GPL1355
brain, frontal cortex: Sample51_e1_le1 brain, frontal cortex Phenytoin frontal cortex 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53463
GPL1355
brain, frontal cortex: Sample52_e1_le1 brain, frontal cortex Phenytoin frontal cortex 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53464
GPL1355
brain, frontal cortex: Sample53_e1_le1 brain, frontal cortex Phenytoin frontal cortex 4 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53465
GPL1355
brain, frontal cortex: Sample54_e1_le1 brain, frontal cortex Phenytoin frontal cortex 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53466
GPL1355
brain, frontal cortex: Sample55_e1_le1 brain, frontal cortex Phenytoin frontal cortex 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53467
GPL1355
brain, frontal cortex: Sample56_e1_le1 brain, frontal cortex Phenytoin frontal cortex 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive phenytoin (75 mg/kg x 2) through a gastric tube twice daily for 90 days.
GSM53468
GPL1355
brain, frontal cortex: Sample57_e1_le1 brain, frontal cortex Control frontal cortex 1 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53469
GPL1355
brain, frontal cortex: Sample58_e1_le1 brain, frontal cortex Control frontal cortex 2 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53470
GPL1355
brain, frontal cortex: Sample59_e1_le1 brain, frontal cortex Control frontal cortex 3 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53471
GPL1355
brain, frontal cortex: Sample60_e1_le1 brain, frontal cortex Control frontal cortex 5 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53472
GPL1355
brain, frontal cortex: Sample61_e1_le1 brain, frontal cortex Control frontal cortex 6 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
GSM53473
GPL1355
brain, frontal cortex: Sample62_e1_le1 brain, frontal cortex Control frontal cortex 7 Treatment, type=compound_based_treatment, description=Male Wistar rats receive control solution (N=7 in each group) through a gastric tube twice daily for 90 days.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes